This study is an important first step in the development of a national policy on illegal drugs. It assesses two recent cost-effectiveness studies on cocaine control policy: one by RAND, Controlling Cocaine: Supply Versus Demand Programs, and the other by the Institute of Defense Analyses, An Empirical Examination of Counterdrug Interdiction Program Effectiveness.

This study is an important first step in the development of a national policy on illegal drugs. It assesses two recent cost-effectiveness studies on cocaine control policy: one by RAND, Controlling Cocaine: Supply Versus Demand Programs, and the other by the Institute of Defense Analyses, An Empirical Examination of Counterdrug Interdiction Program Effectiveness.

How should the war on drugs be fought? Everyone seems to agree that the United States ought to use a combination of several different approaches to combat the destructive effects of illegal drug use. Yet there is a remarkable paucity of data and research information that policy makers require if they are to create a useful, realistic policy package-details about drug use, drug market economics, and perhaps most importantly the impact of drug enforcement activities. Informing America's Policy on Illegal Drugs recommends ways to close these gaps in our understanding-by obtaining the necessary data on drug prices and consumption (quantity in addition to frequency); upgrading federal management of drug statistics; and improving our evaluation of prevention, interdiction, enforcement, and treatment efforts. The committee reviews what we do and do not know about illegal drugs and how data are assembled and used by federal agencies. The book explores the data and research information needed to support strong drug policy analysis, describes the best methods to use, explains how to avoid misleading conclusions, and outlines strategies for increasing access to data. Informing America's Policy on Illegal Drugs also discusses how researchers can incorporate randomization into studies of drug treatment and how state and local agencies can compare alternative approaches to drug enforcement. Charting a course toward a better-informed illegal drugs policy, this book will be important to federal and state policy makers, regulators, researchers, program administrators, enforcement officials, journalists, and advocates concerned about illegal drug use.

With budgets squeezed at every level of government, cost-benefit analysis (CBA) holds outstanding potential for assessing the efficiency of many programs. In this first book to address the application of CBA to social policy, experts examine ten of the most important policy domains: early childhood development, elementary and secondary schools, health care for the disadvantaged, mental illness, substance abuse and addiction, juvenile crime, prisoner reentry programs, housing assistance, work-incentive programs for the unemployed and employers, and welfare-to-work interventions. Each contributor discusses the applicability of CBA to actual programs, describing both proven and promising examples. The editors provide an introduction to cost-benefit analysis, assess the programs described, and propose a research agenda for promoting its more widespread application in social policy. Investing in the Disadvantaged considers how to face America’s most urgent social needs with shrinking resources, showing how CBA can be used to inform policy choices that produce social value.

This book concludes that AmericaOs drug policy should be reoriented in several ways to be more effective.